LONDON - AstraZeneca’s COVID-19 vaccine provided strong protection against disease and complete protection against hospitalization and death across all age groups in a late-stage U.S. study, the ...

WASHINGTON -- The top U.S. infectious disease expert said AstraZeneca's suspension of final testing of its COVID-19 vaccine candidate shows "one of the safety valves" built into the studies to spot ...

LONDON (AP) — The European Union’s drug regulatory agency says experts have concluded that the AstraZeneca vaccine is not linked to an overall increase in the risk of blood clots and that the benefits ...

FRANKFURT/LONDON (Reuters) - AstraZeneca's COVID-19 vaccine developed with Oxford University was 79% effective in preventing symptomatic illness in a large trial in Chile, Peru and the United States, ...

The Director General of the Nigeria Centre for Disease Control (NCDC) Dr Chikwe Ihekweazu has assured Nigerians of the safety and efficacy of the Oxford-AstraZeneca vaccine for COVID 19 He said that ...

New results on a possible COVID-19 vaccine from Oxford University and drugmaker AstraZeneca suggest it is safe and about 70% effective. Some experts say that shows it is likely to win approval, but ...